Suppr超能文献

坏死梭杆菌在扁桃体周围脓肿复发中的作用

Implication of Fusobacterium necrophorum in recurrence of peritonsillar abscess.

作者信息

Ali S Ahmed, Kovatch Kevin J, Smith Josh, Bellile Emily L, Hanks John E, Hoff Paul T

机构信息

Department of Otolaryngology Head & Neck Surgery, Ann Arbor, Michigan, U.S.A.

School of Medicine, University of Michigan, Ann Arbor, Michigan, U.S.A.

出版信息

Laryngoscope. 2019 Jul;129(7):1567-1571. doi: 10.1002/lary.27675. Epub 2018 Dec 24.

Abstract

OBJECTIVE

Peritonsillar abscess (PTA) is a common infectious complication of pharyngeal infection managed by otolaryngologists and emergency room physicians. Streptococcus and Fusobacterium (e.g., Fusobacterium necrophorum, FN) species are commonly isolated pathogens. The aim of this study was to determine the implication of culture results on abscess recurrence following drainage.

METHODS

Single-institution retrospective review of patients treated at the University of Michigan between 2000 and 2017. Demographic and clinical outcome data were analyzed, including treatment details, culture data, and recurrence.

RESULTS

One hundred fifty-six of the 990 patients in our study developed recurrence of their abscess (16%). The age ranges most susceptible to recurrence included adolescent (22.9%) and young adult groups (17.1%). Recurrent patients were more likely to have experienced acute progression of symptoms (79% vs. 71%, P = 0.03), trismus (67% vs. 55%, P = 0.006), voice changes (65% vs. 57%, P = 0.04), and dysphagia (72% vs. 61%, P = 0.01) compared to nonrecurrent patients. They were also more likely to have clinical lymphadenopathy noted on initial examination (67% vs. 56%, P = 0.009). Culture data was sent for 852 patients (86%). The presence of FN was significantly more prevalent in the recurrent group (P < 0.0001).

CONCLUSION

There is a high observed prevalence of FN species within PTA aspirates in the recurrent PTA population. PTA aspirate should be sent for anaerobic growth to screen for Fusobacterium species. In addition, follow-up and lower threshold for subsequent tonsillectomy should be considered in this at-risk group.

LEVEL OF EVIDENCE

3 Laryngoscope, 129:1567-1571, 2019.

摘要

目的

扁桃体周脓肿(PTA)是一种常见的咽部感染性并发症,由耳鼻喉科医生和急诊室医生进行处理。链球菌和梭杆菌属(如坏死梭杆菌,FN)是常见的分离病原体。本研究的目的是确定培养结果对引流后脓肿复发的影响。

方法

对2000年至2017年在密歇根大学接受治疗的患者进行单机构回顾性研究。分析人口统计学和临床结局数据,包括治疗细节、培养数据和复发情况。

结果

我们研究的990例患者中有156例出现脓肿复发(16%)。最易复发的年龄范围包括青少年(22.9%)和青年组(17.1%)。与未复发患者相比,复发患者更有可能经历症状的急性进展(79%对71%,P = 0.03)、牙关紧闭(67%对55%,P = 0.006)、声音改变(65%对57%,P = 0.04)和吞咽困难(72%对61%,P = 0.01)。他们在初次检查时也更有可能出现临床淋巴结病(67%对56%,P = 0.009)。852例患者(86%)进行了培养数据送检。FN的存在在复发组中明显更为普遍(P < 0.0001)。

结论

在复发性PTA人群的PTA抽吸物中观察到FN属的高流行率。应将PTA抽吸物送去进行厌氧菌培养以筛查梭杆菌属。此外,对于这一高危人群,应考虑进行随访并降低后续扁桃体切除术的阈值。

证据级别

3 喉镜,129:1567 - 1571,2019年。

相似文献

1
Implication of Fusobacterium necrophorum in recurrence of peritonsillar abscess.
Laryngoscope. 2019 Jul;129(7):1567-1571. doi: 10.1002/lary.27675. Epub 2018 Dec 24.
3
Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark.
Clin Infect Dis. 2009 Nov 15;49(10):1467-72. doi: 10.1086/644616.
4
Tonsillar colonisation of Fusobacterium necrophorum in patients subjected to tonsillectomy.
BMC Infect Dis. 2015 Jul 10;15:264. doi: 10.1186/s12879-015-0975-z.
5
[Treatment of peritonsillar abscess].
Ugeskr Laeger. 2012 Feb 6;174(6):340-3.
6
Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess.
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1733-9. doi: 10.1007/s10096-014-2130-y. Epub 2014 May 9.
7
Peritonsillar abscess: an 8-year retrospective, culture based evaluation of 208 cases.
J Med Microbiol. 2022 Sep;71(9). doi: 10.1099/jmm.0.001576.
8
Parapharyngeal abscess is frequently associated with concomitant peritonsillar abscess.
Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1701-7. doi: 10.1007/s00405-013-2667-x. Epub 2013 Aug 28.
9
Significant pathogens in peritonsillar abscesses.
Eur J Clin Microbiol Infect Dis. 2011 May;30(5):619-27. doi: 10.1007/s10096-010-1130-9. Epub 2010 Dec 22.

引用本文的文献

1
Mucosal emphysematous head and neck infections: Scoping review and a case of emphysematous tonsillitis.
Laryngoscope Investig Otolaryngol. 2024 May 27;9(3):e1274. doi: 10.1002/lio2.1274. eCollection 2024 Jun.
2
Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report.
Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):1013-1015. doi: 10.1007/s12070-022-03203-0. Epub 2022 Dec 6.
4
Emphysematous Cholecystitis Secondary to Fusobacterium nucleatum.
Cureus. 2021 Jun 15;13(6):e15660. doi: 10.7759/cureus.15660. eCollection 2021 Jun.

本文引用的文献

2
Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess.
Cochrane Database Syst Rev. 2016 Dec 23;12(12):CD006287. doi: 10.1002/14651858.CD006287.pub4.
3
4
The role of Fusobacterium necrophorum in pharyngotonsillitis - A review.
Anaerobe. 2016 Dec;42:89-97. doi: 10.1016/j.anaerobe.2016.09.006. Epub 2016 Sep 28.
5
Tonsillar colonisation of Fusobacterium necrophorum in patients subjected to tonsillectomy.
BMC Infect Dis. 2015 Jul 10;15:264. doi: 10.1186/s12879-015-0975-z.
7
Clinical and biochemical characteristics of patients with Fusobacterium necrophorum-positive acute tonsillitis.
Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1457-63. doi: 10.1007/s00405-015-3535-7. Epub 2015 Feb 10.
8
Risk factors for recurrence of peritonsillar abscess.
J Laryngol Otol. 2014 Dec;128(12):1084-8. doi: 10.1017/S002221511400259X. Epub 2014 Nov 17.
9
Epidemiology, clinical history and microbiology of peritonsillar abscess.
Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):549-54. doi: 10.1007/s10096-014-2260-2. Epub 2014 Oct 17.
10
Prognostic factors and effects of early surgical drainage in patients with peritonsillar abscess.
J Infect Chemother. 2014 Nov;20(11):722-5. doi: 10.1016/j.jiac.2014.07.018. Epub 2014 Aug 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验